PF 72
LIVE

Serial Number

79233582

Owner

Tgel Bio Co., Ltd.

Attorney

John P. McCormick

Filing Date

Feb 2, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PF 72 Trademark

Serial Number: 79233582 • Registration: 5736229

PF 72 is a trademark filed by Tgel Bio Co., Ltd. on February 2, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Tgel Bio Co., Ltd.

(Daechi-dong) 4F,

Entity Type: 99

Trademark Details

Filing Date

February 2, 2018

Registration Date

April 30, 2019

Published for Opposition

February 12, 2019

Goods & Services

[ Drug delivery apparatus for medical purposes, namely, using microspheres for embolization; electromagnetic drug delivery apparatus for medical use; drug infusion pump; drug delivery devices; implantable drug delivery pump for use as drug delivery device sold empty; implantable medication infuser for use as drug delivery device sold empty; drug delivery platforms; implantable subcutaneous drug delivery devices sold empty; anaesthetic delivery apparatus; medical drug syringes; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating the inhalation of pharmaceutical preparations; surgical instruments and apparatus; medical products being medical syringes; implants consisting of artificial materials; orthopedic articles, namely, orthopedic walkers and orthopedic supports ]

Drug delivery agents [ consisting of compounds ] that facilitate delivery of a wide range of pharmaceuticals; [ drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; ] [ microspheres used as vehicles to deliver drugs in the nature of pharmaceutical preparations; ] [ pharmaceutical preparations and substances for use in drug delivery in cell and tissue; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery formulations in the form of tablets, capsules, solutions, suspensions, or pellets with tamper resistant properties which facilitate or allow the delivery of a wide range of pharmaceuticals; peptides for drug delivery, namely, drug delivery agents consisting of peptides attached to drugs that facilitate delivery of pharmaceutical preparations; carriers for drug delivery, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; drug delivery agents that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of pharmaceutical preparations; ] drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals [ ; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Feb 23, 2026 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Feb 23, 2026 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 71 RECEIVED
Oct 30, 2025 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2024 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jun 30, 2020 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 16, 2020 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 13, 2020 FINO
NEW REPRESENTATIVE AT IB RECEIVED
Mar 6, 2020 NREP
FINAL DISPOSITION NOTICE SENT TO IB
Feb 18, 2020 FICS
FINAL DISPOSITION PROCESSED
Feb 18, 2020 FIMP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 18, 2020 LIMN
CORRECTION UNDER SECTION 7 - PROCESSED
Oct 16, 2019 COC.
ASSIGNED TO PARALEGAL
Oct 16, 2019 PLGL
LIMITATION FROM THE IB EXAMINED AND ENTERED
Sep 25, 2019 LIME
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2019 FICR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 13, 2019 CORN
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2019 R.PR
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 12, 2019 CRCV
LIMITATION OF GOODS RECEIVED FROM IB
Apr 12, 2019 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Apr 4, 2019 LIMG
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Feb 12, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Feb 8, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 23, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 26, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2018 TROA
REFUSAL PROCESSED BY IB
Jul 7, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 21, 2018 RFCS
REFUSAL PROCESSED BY MPU
Jun 21, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jun 12, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 12, 2018 MAFR
ASSIGNED TO EXAMINER
Jun 8, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 8, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 7, 2018 REPR